Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Julius-Kuhn-Archiv ; 425: 489-494, 2010.
Article Dans Anglais | SES-SP, LILACS, SESSP-CTDPROD, SES-SP, SESSP-IALPROD, SES-SP | ID: biblio-1008726
2.
Braz. j. med. biol. res ; 33(11): 1313-5, Nov. 2000. tab
Article Dans Anglais | LILACS | ID: lil-273208

Résumé

Fetal hemoglobin was measured in HIV1/2 patients under treatment with combined therapy (zidovudine and a protease inhibitor). A total of 143 patients and 103 normal individuals were investigated by the quantitative method of Betke and the semi-quantitative acid elution method of Kleihauer. In the normal person, hemoglobin F makes up less than 1 percent and an increase higher than 1.5 percent was observed in 21.4 percent of HIV patients by the method of Betke and in 24.8 percent of HIV-infected patients by the method of Kleihauer. The quantitative biochemical method of Betke showed that the populations were significantly different (two-tailed Mann-Whitney test). The reason for this hemoglobin F increase might be ascribed to the effect of zidovudine or to direct viral action on gamma chain expression. The finding of a higher F cell frequency indicated by the method of Kleihauer rather suggests that there is an increased F cell clone proliferation rather than an increase in hemoglobin F level in every cell


Sujets)
Humains , Hémoglobine foetale/analyse , Infections à VIH/sang , Agents antiVIH/usage thérapeutique , Études cas-témoins , Loi du khi-deux , Précurseurs érythroïdes/effets des médicaments et des substances chimiques , Infections à VIH/traitement médicamenteux , Inhibiteurs de protéase du VIH/usage thérapeutique , Statistique non paramétrique , Zidovudine/usage thérapeutique
SÉLECTION CITATIONS
Détails de la recherche